Germany-based Doctorly secures €9.3M to help doctors manage practice digitally: Know more

Berlin-based Doctorly, a digital-first, cloud-based, fully centralised, practice management platform for doctors, announced on Wednesday that it has raised $10M (approximately €9.39M) in a Series A round of funding.

“We are incredibly motivated to continue to re-digitise how medical practices work and support medical professionals by drastically reducing their highly regulated, core administrative burden,” says the startup in a LinkedIn post.

Investors in this round

The investment came from healthtech giant WELL Health Technologies Corp. and Horizons Ventures, a VC that backs “era-defining” companies to make lasting and positive impact in the world.

Doctorly’s existing investors Speedinvest, The Delta, UNIQA Ventures, Calm/Storm Ventures, and Seedcamp also participated in the round.

The existing investors previously backed the company with €5M in funding in June 2020.

Doctorly: Everything you need to know

Founded in 2018, Doctorly is made up of an international team of serial tech entrepreneurs, doctors, technology experts, and product design specialists. The founders include Samir El-Alami, Anna von Stackelberg, Nicklas Teicke, and Sebastian L.

The startup took four years to build its product before receiving approval from the German regulator Kassenärztliche Bundesvereinigung (KBV) and launching at the beginning of 2022.

Doctorly aims to replace the outdated practice management software being used by doctors in Germany and internationally. With B2B and B2C models, the startup provides all of the digital technology, tools, and support, via a single system, for a doctor to digitally manage their practice, and engage with their patients like never before. 

Capital utilisation

According to sifted, Doctorly looks to scale its services in its home market in 2023 as well as plans to expand its sales and marketing workforce.

Co-founder Samir El-Alami also told sifted that in the future, Doctorly may expand into other European countries once it raises its Series B funding sometime in 2024.